其它目标|Other Targets-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

其它目标

4-Amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride 4-氨基-1-((2R,4R,5R)-3,3-二氟-4-羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮盐酸盐: BJS1824185122111-03-997%; ￥515.0010g

Diphenylcyclopropenone 二苯基环丙烯酮: BJS7635242886-38-498%; ￥754.005g

2-(4-Isobutylphenyl)propanoic acid 2-(4-异丁基苯基)丙酸: BJS498781515687-27-198%; ￥554.001kg

5-(1H-Pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol 5-(1H-吡唑-4-基)-2-(6-((2,2,6,6-四甲基哌啶-4-基)氧基)哒嗪-3-基)苯酚: BJS71944341562338-42-498%; ￥2272.0050mg

3-Hydroxybenzaldehyde 间羟基苯甲醛: BJS2783590100-83-498%; ￥145.00100g

(R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide (R)-2,4-二羟基-N-(3-羟丙基)-3,3-二甲基丁酰胺: BJS455127781-13-099%; ￥158.00100g

L-Histidine hydrochloride hydrate L-组氨酸盐酸盐水合物: BJS31235075934-29-298%; ￥76.0025g

2-[2-(2-Propynyloxy)ethoxy]ethanol 2-[2-(2-丙炔氧基)乙氧基]乙醇: BJS31838467218-43-197%; ￥5521.0025g

Bis(2,5-dioxopyrrolidin-1-yl) adipate 双(2,5-二氧代吡咯烷-1-基)己二酸酯: BJS508473059156-70-697%; ￥174.00250mg

H-N-Me-Pro-OH N-甲基-L-脯氨酸: BJS9462588475-11-697%; ￥2518.0025g

N-(1',2-Dihydroxy-[1,2'-binaphthalen]-4'-yl)-4-methoxybenzenesulfonamide N-(1',2-二羟基-[1,2'-联萘]-4'-基)-4-甲氧基苯磺酰胺: BJS9042288432001-19-998%; ￥1861.0025mg

(E)-1-(3-((E)-3,7-Dimethylocta-2,6-dien-1-yl)-2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one (E)-1-(3-((E)-3,7-二甲基辛-2,6-二烯-1-基)-2,4-二羟基苯基)-3-(4-羟基苯基)丙-2-烯-1-酮: BJS891764562949-76-299%; ￥6852.0025mg

3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-7H-[1,4]dioxino[2,3-g]chromen-7-one 3-(4-羟基-3,5-二甲氧基苯基)-2-(羟甲基)-2,3-二氢-7H-[1,4]二氧环己烷并[2,3-g]苯并吡喃-7-酮: BJS4616267116521-73-498%; ￥5842.005mg

(3R,4S,4aS,9aR)-4a-Acetoxy-3-((1E,3E)-4-carboxypenta-1,3-dien-1-yl)-3-methyl-1-oxo-3,4,4a,5,6,9-hexahydro-1H-4,9a-ethanocyclohepta[c]pyran-7-carboxylic acid (3R,4S,4aS,9aR)-4a-乙酰氧基-3-((1E,3E)-4-羧基戊-1,3-二烯-1-基)-3-甲基-1-氧代-3,4,4a,5,6,9-六氢-1H-4,9a-乙桥环庚并[c]吡喃-7-羧酸: BJS768028182508-35-899%; ￥1823.005mg

17-Epidihydroimperialine (3S,4aS,5R,6aS,6bS,8aS,9S,9aS,12S,15aS,15bR,16aS,16bR)-9,12,16b-三甲基二十四氢苯并[4,5]茚并[1,2-h]吡啶并[1,2-b]异喹啉-3,5,9-三醇: BJS499571223496-43-798%; ￥2915.005mg

N5-((R)-2-(Allylthio)-1-carboxyethyl)-L-glutamine N5-((R)-2-(烯丙硫基)-1-羧基乙基)-L-谷氨酰胺: BJS945422391216-95-498%; ￥7615.0025mg

13,21-Dihydroeurycomanone (1R,2R,3S,3aR,3a1R,4R,6aR,7aS,11S,11aS,11bR)-1,2,3a,4,11-五羟基-3,8,11a-三甲基-1,2,3,3a,4,7,7a,11,11a,11b-十氢-5H-1,3a1-(环氧甲桥)二苯并[de,g]苯并吡喃-5,10(6aH)-二酮: BJS1486151129587-06-098%; ￥8524.0010mg

2-((R)-4-((3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid 2-((R)-4-((3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-二羟基-10,13-二甲基十六氢-1H-环戊并[a]菲-17-基)戊酰氨基)乙烷-1-磺酸: BJS30740712958-04-598%; ￥861.00100mg

(S)-1-((3R,6S,9S,12S,15S)-6-(2-Amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-((S)-sec-butyl)-15-(4-methoxybenzyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosane-3-carbonyl)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide xacetate (S)-1-(((3R,6S,9S,12S,15S)-6-(2-氨基-2-氧代乙基)-9-(3-氨基-3-氧代丙基)-12-((S)-仲丁基)-15-(4-甲氧基苄基)-5,8,11,14,17-五氧代-1-硫杂-4,7,10,13,16-五氮杂环二十烷-3-羰基)-N-((S)-1-(((2-氨基-2-氧代乙基)氨基)-4-甲基-1-氧代戊-2-基)吡咯烷-2-甲酰胺 x乙酸盐: BJS29808551631754-28-398%; ￥10223.00250mg

CCR8 antagonist 1 4-((4-(2-甲基苯甲酰胺基)萘)-1-磺酰胺基)哌啶-1-甲酸乙酯: BJS1488635723304-76-598%; ￥4570.0050mg

1 2 3 4 5 6 7 8 9 ... 374